Trial intelligence / Profile preview

Acetazolamide in Pulmonary Hypertension

NCT02755298Phase 3Completed

Sponsor
University of Zurich
Start
Oct 2016
Primary completion
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of acetazolamide in pulmonary hypertension (PH), sponsored by University of Zurich. Started Oct 2016; status: completed.

02

Drugs

acetazolamide
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on NCT02755298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02755298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call